News

Adjunctive Telaprevir Boosts Response in Chronic HCV

Publish date: June 22, 2011

 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

Both studies were funded by Tibotec and Vertex Pharmaceuticals, which both manufacture telaprevir. Dr. Zeuzem and Dr. Jacobson reported ties to Tibotec and Vertex, as well as to numerous other industry sources.

Pages

Recommended Reading

Longer Imatinib Therapy Improves Outcomes For High-Risk GIST
MDedge Internal Medicine
Link Between Proton Pump Inhibitors, Hip Fractures Confirmed
MDedge Internal Medicine
Multiple Factors Influence Detection of Colorectal Adenomas
MDedge Internal Medicine
Laparoscopic Sleeve Gastrectomy Appears Safe in Major Observational Study
MDedge Internal Medicine
Vancomycin Monotherapy Linked to C. Difficile Recurrence in IBD
MDedge Internal Medicine
Cyclosporine No Better Than Infliximab for Ulcerative Colitis
MDedge Internal Medicine
Continued Aspirin Use Does Not Impede Ulcer Healing
MDedge Internal Medicine
VA Study: Gastric Bypass Does Not Prolong Life in Older, Obese Patients
MDedge Internal Medicine
Pregnancy After Liver Transplant Raises Risk of Graft Loss
MDedge Internal Medicine
Link Between PPIs and C. difficile Inconsistent
MDedge Internal Medicine